Phase 4 Atrial Fibrillation Clinical Trials
27 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 27 trials
Recruiting
Phase 4
Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
Postoperative Atrial Fibrillation
Stanford University600 enrolled1 locationNCT03868150
Recruiting
Phase 4
Colchicine's Effect on Inflammatory Markers
ColchicinePost-operative Atrial FibrillationInflammation in Cardiac Surgery+2 more
Ayesha Ather24 enrolled1 locationNCT07287345
Recruiting
Phase 4
Ondansetron for the Management of Atrial Fibrillation
Atrial Fibrillation
Indiana University80 enrolled3 locationsNCT05844501
Recruiting
Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Atrial FibrillationStroke
Population Health Research Institute2,270 enrolled105 locationsNCT03968393
Recruiting
Phase 4
Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
Persistent Atrial Fibrillation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau312 enrolled1 locationNCT07273994
Recruiting
Phase 4
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
Persistent Atrial FibrillationParoxysmal Atrial FibrillationLong-standing Persistent Atrial Fibrillation
Vivek Reddy275 enrolled5 locationsNCT06765356
Recruiting
Phase 4
COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
Atrial Fibrillation
Ottawa Hospital Research Institute3,018 enrolled8 locationsNCT04642430
Recruiting
Phase 4
Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
Critical IllnessNew Onset Atrial Fibrillation
Dr. Stephanie Sibley200 enrolled4 locationsNCT05829317
Recruiting
Phase 4
The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
Atrial FibrillationCoronary Artery DiseaseCoronary Artery Bypass Grafting+1 more
Tomsk Cardiology Research Institute140 enrolled1 locationNCT06798714
Recruiting
Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
Atrial Fibrillation
University of Illinois at Chicago162 enrolled4 locationsNCT02347111
Recruiting
Phase 4
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
Left Atrial Appendage ClosureAspirinNonvalvular Atrial Fibrillation+2 more
OCEAN-SHD Study Group500 enrolled21 locationsNCT07125417
Recruiting
Phase 4
Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
Atrial Fibrillation
University of Birmingham3,000 enrolled1 locationNCT04700826
Recruiting
Phase 4
The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)
Atrial Fibrillation Patients With Intermediate Stroke Risk
Yonsei University1,800 enrolled1 locationNCT04437654
Recruiting
Phase 4
Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Atrial Fibrillation (AF)Percutaneous Coronary Intervention (PCI)Oral Anticoagulation+1 more
Insel Gruppe AG, University Hospital Bern3,010 enrolled15 locationsNCT05955365
Recruiting
Phase 4
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
Atrial FibrillationStrokeAnticoagulant Adverse Reaction+1 more
China National Center for Cardiovascular Diseases4,374 enrolled1 locationNCT06108414
Recruiting
Phase 4
DUTCH Weight Control in Atrial Fibrillation Study
ObesityWeight LossAtrial Fibrillation
Rijnstate Hospital280 enrolled1 locationNCT06184633
Recruiting
Phase 4
Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients
Atrial Fibrillation
National Institute of Cardiology, Warsaw, Poland80 enrolled1 locationNCT05660811
Recruiting
Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Heart FailureAtrial FibrillationDiastolic Heart Failure
Electrophysiology Research Foundation360 enrolled9 locationsNCT04160000
Recruiting
Phase 4
Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
Atrial FibrillationAnticoagulant Adverse ReactionLeft Atrial Appendage Absent
Odense University Hospital1,220 enrolled6 locationsNCT06401616
Recruiting
Phase 4
Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation
Non Valvular Atrial Fibrillation
China National Center for Cardiovascular Diseases120 enrolled1 locationNCT05320627